首都医科大学学报 ›› 2008, Vol. 29 ›› Issue (3): 266-269.

• 专题报道 • 上一篇    下一篇

血小板活化与冠状动脉粥样硬化性心脏病和血瘀证的关系

陈可冀, 薛梅, 殷惠军   

  1. 中国中医科学院西苑医院心血管中心
  • 收稿日期:2008-04-16 修回日期:1900-01-01 出版日期:2008-06-24 发布日期:2008-06-24
  • 通讯作者: 殷惠军

The Relationship between Platelet Activation and Coronary Heart Disease and Blood-stasis Syndrome

Chen Keji, Xue Mei, Yin Huijun   

  1. Department of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
  • Received:2008-04-16 Revised:1900-01-01 Online:2008-06-24 Published:2008-06-24

摘要: 血小板膜糖蛋白在血小板黏附、聚集和释放反应中起关键作用,是血小板活化的特异性分子标志物.研究证实血小板膜糖蛋白,特别是CD62P、CD63和PAC-1的活性检测可较为灵敏且特异地反映冠状动脉粥样硬化性心脏病(冠心病)的发生发展过程,且随着病情程度的加重上述糖蛋白的表达也相应增强.血瘀证是临床最常见证候之一,研究证实多种疾病的血瘀证患者存在血小板活化现象,而不同病种之间的血小板活化表达量则无明显差异.活化血小板膜糖蛋白测定不仅可以对冠心病,特别是急性心肌梗死的早期诊断、病程进展判断等起辅助作用,还可作为血瘀证的微观辨证指标之一.

关键词: 血小板活化, 冠心病, 血瘀证, 血小板膜糖蛋白

Abstract: The platelet membrane glycoprotein plays a key role in the adhesion,aggregation and release of platelets,and is the specific marker for platelet activation.Many studies have shown that the activity of the platelet membrane glycoprotein,especially CD62P,CD63 and PAC-1,can reflect the pathogenesis and development of coronary heart disease sensitively and specifically,and its expression can be influenced by the pathological conditions.Blood-stasis syndrome is one of the most common clinical syndromes.Patients having different diseases with blood-stasis syndrome do have platelet activation,but in terms of the platelet activity,there is no difference among them.Measurement of the activated platelet membrane glycoprotein not only provides help to diagnose acute myocardial infarction sooner and estimate the state of the illness,but also can be served as one of the indicators of micro-dialectical discrimination of illness.

Key words: platelet activation, coronary heart disease, blood-stasis syndrome, platelet membrane glycoprotein

中图分类号: